ATF2 (Ab-112 or 94) Antibody

What is ATF2 and why are phospho-specific antibodies important in cellular signaling research?

ATF2 (Activating Transcription Factor 2) is a multifunctional protein belonging to the leucine zipper family of DNA binding proteins. It serves as both a transcription factor and a histone acetyltransferase (HAT). ATF2's importance stems from its role in:

• Binding to cAMP-responsive elements (CRE) as either a homodimer or heterodimer with c-Jun

• Stimulating CRE-dependent transcription

• Specifically acetylating histones H2B and H4, suggesting direct chromatin modification capabilities

• Participating in DNA damage response pathways

Phospho-specific antibodies are crucial because ATF2 function is tightly regulated through phosphorylation events. The phosphorylation state of Ser112 (sometimes annotated as Ser94 depending on isoform nomenclature) represents a specific activation state with distinct downstream effects. Using phospho-specific antibodies allows researchers to monitor ATF2 activation dynamics rather than mere protein presence.

What are the optimal applications and dilutions for ATF2 (Ab-112/94) antibodies?

Based on manufacturer specifications, ATF2 (Ab-112/94) antibodies can be utilized across multiple applications with the following recommended dilutions:

Optimization notes:

• For Western blotting, expected molecular weight varies by phosphorylation state, with observed bands typically at 60-70 kDa

• For IHC applications, antigen retrieval methods may significantly impact results; both citrate buffer (pH 6.0) and TE buffer (pH 9.0) have been successfully employed

• It is recommended to titrate the antibody for each specific application and sample type to achieve optimal signal-to-noise ratio

How should researchers validate the specificity of an ATF2 phospho-Ser112 antibody?

Validating phospho-specific antibodies requires multiple complementary approaches:

• Phosphatase treatment controls: Treating one sample with lambda phosphatase should eliminate signal from phospho-specific antibodies while total ATF2 signal remains unchanged

• Stimulation experiments: Compare samples from cells under conditions known to induce ATF2 phosphorylation (e.g., amino acid deprivation , hyperosmotic stress) against unstimulated controls

• Peptide competition assays: Pre-incubating the antibody with phosphorylated vs. non-phosphorylated peptides corresponding to the Ser112 region should show differential blocking of antibody binding

• Knockout/knockdown validation: Using ATF2 knockout or knockdown samples as negative controls; several published studies have employed this approach

• Cross-reactivity assessment: Verify that the antibody detects only phosphorylated ATF2 and not other phosphorylated proteins; most commercial antibodies report no cross-reactivity with other proteins

What is the temporal relationship between ATF2 phosphorylation and histone acetylation during stress responses?

Research on amino acid deprivation stress provides important insights into ATF2 phosphorylation kinetics and its relationship to histone acetylation:

• Temporal sequence in amino acid deprivation:

  • ATF2 phosphorylation at Thr71 is detectable within 30 minutes of leucine deprivation

  • Phosphorylation reaches maximum levels after approximately 2 hours

  • Histone H4 and H2B acetylation follows ATF2 phosphorylation

  • CHOP mRNA expression increases subsequent to these epigenetic changes

These findings suggest a mechanistic sequence where ATF2 phosphorylation precedes its histone acetyltransferase activity, leading to chromatin remodeling and transcriptional activation. This sequence provides a framework for designing time-course experiments when studying ATF2-mediated transcriptional responses.

Notably, while ATF4 binding to the CHOP AARE (Amino Acid Response Element) increases during amino acid deprivation, ATF2 binding remains constitutive throughout the stress response, with phosphorylation state being the key regulatory event .

How can researchers differentiate between various ATF2 phosphorylation sites and their distinct functions?

ATF2 contains multiple phosphorylation sites with different functional consequences:

For experimental differentiation:

• Use site-specific phospho-antibodies: Select antibodies that recognize specific phosphorylation sites

• Employ phospho-mimetic mutants: Create ATF2 constructs with S→D or T→E mutations at specific sites to mimic constitutive phosphorylation

• Design kinase inhibition experiments: Use specific inhibitors for kinases known to target different sites:

  • p38 MAPK inhibitors for Thr69/Thr71 phosphorylation

  • ATM inhibitors for Ser490/Ser498 phosphorylation

• Conduct pathway-specific activation: Use distinct stimuli to preferentially activate specific pathways:

  • Growth factors for ERK pathway (Thr71)

  • Hyperosmotic stress for PLK3 pathway

  • DNA damaging agents for ATM-mediated phosphorylation

What are recommended strategies for optimizing immunoprecipitation with ATF2 phospho-specific antibodies?

Immunoprecipitation with phospho-specific ATF2 antibodies requires special considerations:

• Phosphatase inhibition: Include comprehensive phosphatase inhibitor cocktails in lysis buffers (e.g., sodium fluoride, sodium orthovanadate, β-glycerophosphate, sodium pyrophosphate)

• Gentle lysis conditions: Use buffers containing:

  • 50 mM Tris-HCl, pH 7.4

  • 150 mM NaCl

  • 1% NP-40 or Triton X-100

  • 0.5% sodium deoxycholate

  • Protease and phosphatase inhibitor cocktails

• Antibody amounts: Use 2-5 μg antibody per mg of total protein lysate

• Pre-clearing strategy: Pre-clear lysates with protein A/G beads to reduce non-specific binding

• Validation controls:

  • IgG control immunoprecipitation

  • Input sample (5-10% of lysate used for IP)

  • Flow-through sample to assess IP efficiency

• Detection strategy: For maximal sensitivity, consider:

  • Detecting immunoprecipitated ATF2 with a different ATF2 antibody recognizing a distant epitope

  • Using high-sensitivity chemiluminescence substrates

  • Employing TrueBlot® secondary antibodies to minimize detection of IP antibody heavy chains

How should researchers interpret changes in ATF2 phosphorylation in relation to its various functional roles?

ATF2 functions as both a transcription factor and a histone acetyltransferase, making interpretation complex:

• Transcriptional activity assessment:

  • Monitor CRE-dependent reporter gene expression

  • Perform ChIP assays for ATF2 binding to target gene promoters

  • Assess expression of known ATF2 target genes

• HAT activity evaluation:

  • Conduct ChIP assays focusing on H2B and H4 acetylation at ATF2 target genes

  • Perform in vitro HAT assays with immunoprecipitated ATF2

  • Compare the timing of ATF2 phosphorylation with subsequent histone acetylation

• DNA damage response function:

  • Evaluate co-localization with DNA damage markers

  • Assess interaction with ATM and other DNA damage response proteins

  • Monitor ATF2 nuclear/cytoplasmic distribution

• Experimental design consideration: The temporal dynamics of ATF2 phosphorylation are critical. Research shows phosphorylation at Thr71 occurs within 30 minutes of stress, peaks at 2 hours, and precedes histone acetylation and target gene expression changes .

What methodological approaches can resolve contradictory results between phospho-ATF2 and total ATF2 detection?

When facing contradictory results:

• Antibody validation:

  • Confirm antibody specificity through peptide competition assays

  • Validate with phosphatase treatment controls

  • Use ATF2 knockout/knockdown samples as negative controls

• Technical approach optimization:

  • For Western blotting: Strip and reprobe the same membrane to directly compare phospho and total signals

  • For IHC/IF: Perform sequential staining on the same section/cells with different fluorophores

• Sample preparation considerations:

  • Ensure rapid sample processing to preserve phosphorylation status

  • Verify complete protease and phosphatase inhibition

  • Consider subcellular fractionation as phospho-ATF2 distribution may differ from total ATF2

• Quantitative analysis:

  • Calculate phospho-to-total ATF2 ratios rather than absolute values

  • Perform densitometry with appropriate normalization

  • Consider phosphorylation site-specific effects when interpreting results

• Experimental design:

  • Include positive controls like stress-induced samples with known ATF2 phosphorylation patterns

  • Design time-course experiments to capture the dynamic nature of phosphorylation events

How do storage and handling conditions affect ATF2 antibody performance?

Proper handling of ATF2 antibodies is critical for maintaining performance:

Performance optimization notes:

• Freeze-thaw cycles: Minimize; each cycle may reduce antibody activity by 10-15%

• Working dilutions: Prepare fresh dilutions for each experiment rather than storing diluted antibody

• Antibody stabilizers: Some formulations include 0.5% BSA or other stabilizers which should not be removed

• Temperature transitions: Allow antibodies to equilibrate to room temperature before opening to prevent condensation and contamination

• Centrifugation: Briefly centrifuge antibody vials before opening to collect solution at the bottom

Adherence to these handling guidelines helps ensure consistent performance and reproducible results across experiments.

What are the critical parameters for designing ATF2 phosphorylation studies in stress response models?

When designing experiments to study ATF2 phosphorylation during stress responses:

• Timing considerations:

  • Include early timepoints (15-30 minutes) to capture initial phosphorylation events

  • Extend to later timepoints (2-4 hours) to observe subsequent histone modifications and gene expression

  • Data shows ATF2 phosphorylation is detectable after 30 minutes of leucine deprivation and reaches maximum levels within 2 hours

• Stress model selection:

  • Amino acid deprivation: Induces ATF2 phosphorylation and activates CHOP gene expression

  • Hyperosmotic stress: Triggers PLK3-mediated phosphorylation

  • Growth factors: Activate ERK pathways leading to Thr71 phosphorylation

  • DNA damaging agents: Induce ATM-mediated phosphorylation at Ser490/Ser498

• Control conditions:

  • Include appropriate vehicle controls

  • Design time-matched control samples

  • Consider pathway-specific positive controls

• Detection methods optimization:

  • Western blot: Focus on both phospho-specific and total ATF2 detection

  • ChIP: Examine ATF2 binding and associated histone modifications at target genes

  • IF/IHC: Evaluate subcellular localization changes following phosphorylation

• Validation approaches:

  • Use kinase inhibitors to block specific phosphorylation events

  • Employ phospho-mimetic or phospho-deficient ATF2 mutants

  • Consider siRNA knockdown of specific kinases or ATF2 itself as controls